Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period Caroline SvenjebyLouise CarstamAlba Corell Research Open access 25 November 2022 Pages: 535 - 543
Endoscopic endonasal approach for resection of a recurrent spheno-orbital meningioma resulting in complete resolution of visual symptoms: A case report and review of literature Won KimFarinaz GhodratiIsaac Yang Review Open access 29 November 2022 Pages: 545 - 553
High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI Nicholas T. GamboaBrendan CrabbRandy L. Jensen Research 17 November 2022 Pages: 555 - 565
Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis David GorodezkiJulian ZipfelMartin U. Schuhmann Case Study Open access 01 November 2022 Pages: 567 - 576
The role of [18F]fluorodopa positron emission tomography in grading of gliomas Joy R. RoachPuneet PlahaGeoff S. Higgins Review Open access 24 November 2022 Pages: 577 - 589
Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases Grant McKenzieJeremy GaskinsShiao Woo Case Study 01 November 2022 Pages: 591 - 599
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates Laurent-Olivier RoyMyriam LemelinDavid Fortin Research 07 November 2022 Pages: 601 - 609
Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients Cecil ten CateSandra M. H. HuijsMartinus P. G. Broen Research Open access 17 November 2022 Pages: 611 - 618
Neurocognition in adults with intracranial tumors: does location really matter? Charlotte SleursCatharina M. L. ZegersDaniëlle B. P. Eekers Research Open access 08 November 2022 Pages: 619 - 629
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study Shujie ZhouFei RenZhaoqin Huang Research 08 November 2022 Pages: 631 - 642
Long term survivors of stereotactic radiosurgery for brain metastases: do distant brain failures reach a plateau and what factors are associated with a brain metastasis velocity of zero? Claire M. LanierJane PearceMichael D. Chan Research 06 November 2022 Pages: 643 - 648
Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases Elaine A. C. AlbersMichiel B. de RuiterSanne B. Schagen Research 01 December 2022 Pages: 649 - 658
High dose craniospinal irradiation as independent risk factor of permanent alopecia in childhood medulloblastoma survivors: cohort study and literature review C. SatragnoA. VerricoL. Belgioia Research Open access 12 November 2022 Pages: 659 - 668
Utility of 5-ALA for fluorescence-guided resection of brain metastases: a systematic review Harshal A. ShahSandra LeskinenRandy S. D’Amico Review 12 November 2022 Pages: 669 - 675
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres Seo Jin KimSoo Jeong ParkSeok-Gu Kang Research 17 November 2022 Pages: 677 - 689
Utilization of neoadjuvant stereotactic radiosurgery for the treatment of brain metastases requiring surgical resection: a topic review Sujay RajkumarYun LiangMatthew J. Shepard Review 14 November 2022 Pages: 691 - 705
Performing real time neuropsychological testing during awake craniotomy: are dexmedetomidine or propofol the same? A preliminary report Barbara TomasinoIlaria GuarracinoMiran Skrap Research 14 November 2022 Pages: 707 - 716
Association of extent of resection and functional outcomes in diffuse low-grade glioma: systematic review & meta-analysis Mustafa ElsheikhElsie BridgmanMichael Tin Chung Poon Review Open access 21 November 2022 Pages: 717 - 724
Impact of tumor-associated syrinx on outcomes following resection of primary ependymomas of the spinal cord Zach PenningtonAnthony L. MikulaMichelle J. Clarke Research 18 November 2022 Pages: 725 - 733
Erythroblastic oncogene B-2 status and intracranial metastatic disease in patients with gastrointestinal cancer: a systematic review Madison ShermanKarolina GaebeSunit Das Review 13 November 2022 Pages: 735 - 742
Plasma IL13Rα2 as a novel liquid biopsy biomarker for glioblastoma Vladimir KhristovDarya NesterovaJames Connor Research 27 November 2022 Pages: 743 - 752
Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis Rafał ChojakMarta Koźba-GosztyłaBogdan Czapiga Review Open access 30 November 2022 Pages: 753 - 761
Correction to: Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis Rachel ThommenSyed Faraz KazimChristian A. Bowers Correction 12 December 2022 Pages: 763 - 763
